Archive | Xeljanz (Tofacitinib)

Xeljanz (Tofacitinib) Medication for Ulcerative Colitis

XELJANZ® (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis On May 30th, 2018, the Pfizer corporation, announced that the Food and Drug Administration (FDA) has approved its application to allow for Xeljanz to be used by ulcerative colitis patients who meet certain criteria. There are some more details listed on the Pfizer […]

Continue Reading 3

iHaveUC.com is located in Menlo Park, California - United States 94025 - (415) 952-8111